DK0612242T3 - Anvendelse af ren S(+)-isomer af fluoxetin til fremstilling af et medikament mod migræne - Google Patents
Anvendelse af ren S(+)-isomer af fluoxetin til fremstilling af et medikament mod migræneInfo
- Publication number
- DK0612242T3 DK0612242T3 DK92906545T DK92906545T DK0612242T3 DK 0612242 T3 DK0612242 T3 DK 0612242T3 DK 92906545 T DK92906545 T DK 92906545T DK 92906545 T DK92906545 T DK 92906545T DK 0612242 T3 DK0612242 T3 DK 0612242T3
- Authority
- DK
- Denmark
- Prior art keywords
- fluoxetine
- pure
- isomer
- compositions
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79303691A | 1991-11-15 | 1991-11-15 | |
| PCT/US1992/000888 WO1993009769A1 (en) | 1991-11-15 | 1992-02-05 | Methods and compositions utilizing pure s(+) isomer fluoxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0612242T3 true DK0612242T3 (da) | 2003-10-20 |
Family
ID=25158891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92906545T DK0612242T3 (da) | 1991-11-15 | 1992-02-05 | Anvendelse af ren S(+)-isomer af fluoxetin til fremstilling af et medikament mod migræne |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1208838A3 (es) |
| JP (2) | JPH07500812A (es) |
| AT (1) | ATE244563T1 (es) |
| AU (2) | AU1373692A (es) |
| CA (1) | CA2123704C (es) |
| DE (1) | DE69233124T2 (es) |
| DK (1) | DK0612242T3 (es) |
| ES (1) | ES2197144T3 (es) |
| WO (1) | WO1993009769A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2174864T3 (es) * | 1993-06-28 | 2002-11-16 | Wyeth Corp | Nuevos tratamientos que utilizan derivados de fenetilo. |
| ES2082723B1 (es) * | 1994-07-20 | 1996-10-01 | Lilly Sa | Formulacion farmaceutica de fluoxetina en forma dispersable. |
| US6548084B2 (en) | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
| ES2103682B1 (es) * | 1995-09-20 | 1998-04-01 | Lilly Sa | Composicion farmaceutica oral de fluoxetina, solida y con caracteristicas organolepticas mejoradas. |
| AR021155A1 (es) | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
| US6846957B2 (en) | 2002-11-22 | 2005-01-25 | Board Of Regents, The University Of Texas System | Synthesis of 3-aminomethyl-1-propanol, a fluoxetine precursor |
| CN111643475A (zh) * | 2020-07-20 | 2020-09-11 | 华益药业科技(安徽)有限公司 | 一种氟西汀胶囊生产工艺 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA817863B (en) * | 1980-11-14 | 1983-06-29 | Lilly Co Eli | (-)n-methyl-3-(2-methylphenoxy)-3-phenylpropylamnie,antidepressant |
-
1992
- 1992-02-05 EP EP02003532A patent/EP1208838A3/en not_active Withdrawn
- 1992-02-05 AT AT92906545T patent/ATE244563T1/de not_active IP Right Cessation
- 1992-02-05 DE DE69233124T patent/DE69233124T2/de not_active Expired - Fee Related
- 1992-02-05 AU AU13736/92A patent/AU1373692A/en not_active Abandoned
- 1992-02-05 ES ES92906545T patent/ES2197144T3/es not_active Expired - Lifetime
- 1992-02-05 DK DK92906545T patent/DK0612242T3/da active
- 1992-02-05 EP EP92906545A patent/EP0612242B1/en not_active Expired - Lifetime
- 1992-02-05 CA CA002123704A patent/CA2123704C/en not_active Expired - Fee Related
- 1992-02-05 JP JP4506297A patent/JPH07500812A/ja active Pending
- 1992-02-05 WO PCT/US1992/000888 patent/WO1993009769A1/en active IP Right Grant
-
1997
- 1997-04-17 AU AU18917/97A patent/AU1891797A/en not_active Abandoned
-
2003
- 2003-08-28 JP JP2003304079A patent/JP2004002474A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69233124T2 (de) | 2004-02-19 |
| EP0612242B1 (en) | 2003-07-09 |
| EP0612242A4 (en) | 1997-01-15 |
| EP1208838A2 (en) | 2002-05-29 |
| ATE244563T1 (de) | 2003-07-15 |
| AU1891797A (en) | 1997-06-19 |
| CA2123704A1 (en) | 1993-05-27 |
| JPH07500812A (ja) | 1995-01-26 |
| CA2123704C (en) | 2003-01-21 |
| EP1208838A3 (en) | 2003-07-09 |
| AU1373692A (en) | 1993-06-15 |
| DE69233124D1 (de) | 2003-08-14 |
| ES2197144T3 (es) | 2004-01-01 |
| EP0612242A1 (en) | 1994-08-31 |
| WO1993009769A1 (en) | 1993-05-27 |
| JP2004002474A (ja) | 2004-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60216830D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen | |
| DK0415613T3 (da) | Anvendelse af sertralin til behandling af præmatur ejakulation | |
| DK1346041T3 (da) | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom | |
| AR035158A1 (es) | Inhibidores de recaptacion de norepinefrina altamente selectivos y metodo para usar los mismos | |
| DE60134453D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von ZNS und anderen Krankheiten | |
| DE59109222D1 (de) | Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen | |
| CY1114645T1 (el) | Συνθεση αλατος φεντανυλης για ρινικη χορηγηση | |
| DE69228938D1 (de) | Methode und zusammensetzungen zur behandlung von zerebralparalyse | |
| AR026084A1 (es) | Heterociclos de nitrogeno biciclicos | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| ATE450269T1 (de) | Peptid pyyä3-36ü zur behandlung von stoffwechselkrankheiten | |
| NO952418D0 (no) | Antipyretiske og analgetiske metoder og sammensetninger som inneholder optisk ren R-ketorolak | |
| DK1678172T3 (da) | Azabicykliske forbindelser til lindring af smerte og behandling af sygdomme i centralnervesystemet | |
| RU2004110041A (ru) | Фармацевтическая композиция, содержащая габапентин или его аналог и альфа-аминоамид, и ее применение в качестве анальгетика | |
| DE122009000036I1 (de) | Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion | |
| DK0612242T3 (da) | Anvendelse af ren S(+)-isomer af fluoxetin til fremstilling af et medikament mod migræne | |
| ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
| HUP0401934A2 (hu) | Enantiomerekben dúsított demetil- és didemetil- citalopram metabolitok alkalmazása depresszió és más központi idegrendszeri rendellenességek esetében | |
| BG105218A (en) | The use of optically pure (+) norcisapride for treating gastro-esophageal reflux disease | |
| DE69626916D1 (de) | Sertralin zur Behandlung von Post-Myocard-Infarkt-Patienten | |
| DE69825879D1 (de) | Pharmazeutische zusammensetzungen welche aryl-substituierte olefinische amin-verbindungen enthalten | |
| DK0415612T3 (da) | Anvendelse af sertralin til behandling af afhængigheder af kemiske stoffer | |
| ATE353887T1 (de) | Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze | |
| UY27037A1 (es) | Composición de apomorfina para tratar la disfunción sexual con niveles específicos de concentración en plasma | |
| ECSP003554A (es) | Inhibidores altamente selectivos para la recuperacion de la norepinefrina y metodos para utilizar los mismos |